NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Verastem Inc (NASDAQ: VSTM)
VSTM Technical Analysis
5
As on 9th Jun 2023 VSTM SHARE Price closed @ 10.55 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1.19 & Strong Buy for SHORT-TERM with Stoploss of 1.59 we also expect STOCK to react on Following IMPORTANT LEVELS. |
VSTMSHARE Price
Open | 11.21 | Change | Price | % |
High | 11.21 | 1 Day | -0.61 | -5.47 |
Low | 10.30 | 1 Week | 9.53 | 934.31 |
Close | 10.55 | 1 Month | 10.16 | 2605.13 |
Volume | 213200 | 1 Year | 8.27 | 362.72 |
52 Week High 12.06 | 52 Week Low 0.30 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
VSTM Daily Charts |
VSTM Intraday Charts |
Whats New @ Bazaartrend |
VSTM Free Analysis |
|
VSTM Important Levels Intraday
RESISTANCE | 12.30 |
RESISTANCE | 11.74 |
RESISTANCE | 11.39 |
RESISTANCE | 11.05 |
SUPPORT | 10.05 |
SUPPORT | 9.71 |
SUPPORT | 9.36 |
SUPPORT | 8.80 |
VSTM Forecast March 2024
4th UP Forecast | 12.01 |
3rd UP Forecast | 11.54 |
2nd UP Forecast | 11.25 |
1st UP Forecast | 10.96 |
1st DOWN Forecast | 10.14 |
2nd DOWN Forecast | 9.85 |
3rd DOWN Forecast | 9.56 |
4th DOWN Forecast | 9.09 |
VSTM Weekly Forecast
4th UP Forecast | 11.19 |
3rd UP Forecast | 10.98 |
2nd UP Forecast | 10.86 |
1st UP Forecast | 10.73 |
1st DOWN Forecast | 10.37 |
2nd DOWN Forecast | 10.24 |
3rd DOWN Forecast | 10.12 |
4th DOWN Forecast | 9.91 |
VSTM Forecast2024
4th UP Forecast | 35.68 |
3rd UP Forecast | 27.62 |
2nd UP Forecast | 22.64 |
1st UP Forecast | 17.66 |
1st DOWN Forecast | 3.44 |
2nd DOWN Forecast | -1.54 |
3rd DOWN Forecast | -6.52 |
4th DOWN Forecast | -14.58 |
Verastem Inc ( NASDAQ USA Symbol : VSTM )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
VSTM Other Details
Segment | EQ | |
Market Capital | 466355616.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
VSTM Address
VSTM Latest News
VSTM Business Profile
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing medicines to enhance the life of cancer patients. Its product in development include VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) inhibitor that blocks MEK kinase activity and the ability of RAF to phosphorylate MEK. The company also engages in developing RAMP 201, an adaptive two-part multicenter open label trial to evaluate the efficacy and safety of VS-6766 and in combination with defactinib, an oral small molecule inhibitor of focal adhesion kinase (FAK) in patients with recurrent low grade serous ovarian cancer; and RAMP 202, which is in Phase 2 trial to evaluate the safety of VS-6766 in combination with defactinib in patients with KRAS mutant non-small cell lung cancer following treatment with a platinum-based regimen and immune checkpoint inhibitor. Verastem, Inc. has license agreements with Chugai Pharmaceutical Co., Ltd. for the development, commercialization, and manufacture of products containing VS-6766; and Pfizer Inc. to research, develop, manufacture, and commercialize products containing Pfizer's inhibitors of FAK for therapeutic, diagnostic and prophylactic uses in humans. The company was incorporated in 2010 and is headquartered in Needham, Massachusetts. Address: 117 Kendrick Street, Needham, MA, United States, 02494
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service